These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23167572)

  • 41. In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.
    Chen YC; Liang W; Hu JL; He GL; Wu XJ; Liu XF; Zhang J; Hu XQ
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):33-43. PubMed ID: 25354895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation.
    Steib A; Jacoberger B; Von Bandel M; Beck F; Beller JP; Boudjema K; Koffel JC; Otteni JC
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1873-6. PubMed ID: 8239599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simple liquid chromatographic method for the determination of ornidazole and metronidazole in human serum.
    Róna K; Gachályi B
    J Chromatogr; 1987 Sep; 420(1):228-30. PubMed ID: 3667826
    [No Abstract]   [Full Text] [Related]  

  • 44. Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report.
    Sanmukhani J; Shah V; Baxi S; Tripathi C
    Br J Clin Pharmacol; 2010 Jun; 69(6):703-4. PubMed ID: 20565463
    [No Abstract]   [Full Text] [Related]  

  • 45. HPLC-DAD evidence of the oscillatory chiral conversion of phenylglycine.
    Sajewicz M; Gontarska M; Kowalska T
    J Chromatogr Sci; 2014 Apr; 52(4):329-33. PubMed ID: 23572320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective Pharmacokinetics and Chiral Inversions of Some Chiral Hydroxy Group Drugs.
    Chen F; Bai Q; Wang Q; Chen S; Ma X; Cai C; Wang D; Waqas A; Gong P
    Curr Pharm Biotechnol; 2020; 21(15):1632-1644. PubMed ID: 32718284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of ornidazole in human plasma and red blood cells using high-performance liquid chromatography.
    Groppi A; Papa P; Montagna M; Carosi G
    J Chromatogr; 1986 Aug; 380(2):437-42. PubMed ID: 3760074
    [No Abstract]   [Full Text] [Related]  

  • 48. Disulfiram-like Reaction with Ornidazole.
    Guler S; Aytar H; Soyuduru M; Ramadan H
    Am J Emerg Med; 2015 Sep; 33(9):1330.e7-8. PubMed ID: 25812749
    [No Abstract]   [Full Text] [Related]  

  • 49. Determination of ornidazole and its main metabolites in biological fluids.
    Heizmann P; Geschke R; Zinapold K
    J Chromatogr; 1990 Dec; 534():233-40. PubMed ID: 2094712
    [No Abstract]   [Full Text] [Related]  

  • 50. Measurement of ornidazole by high-performance liquid chromatography.
    Merdjan H; Bonnat C; Singlas E; Diquet B
    J Chromatogr; 1983 Apr; 273(2):475-80. PubMed ID: 6863462
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma levels after a single oral dose of 1.5 g ornidazole.
    Matheson I; Johannessen KH; Bjorkvoll B
    Br J Vener Dis; 1977 Aug; 53(4):236-9. PubMed ID: 922457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Zn
    Nandy P; Singha S; Banyal N; Kumar S; Mukhopadhyay K; Das S
    RSC Adv; 2020 Jun; 10(39):23286-23296. PubMed ID: 35520323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ornidazole-induced ataxia in an Indian woman: A case report.
    Gopinath KG; Wilson BP; Viggeswarpu S; Mathews PK; Mani S
    SAGE Open Med Case Rep; 2015; 3():2050313X15621857. PubMed ID: 27489705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity of laevo-leucovorin and dose-lowering.
    Lonardi F; Jirillo A; Bonciarelli G; Pavanato G; Balli M
    Eur J Cancer; 1992; 28A(4-5):1007-8. PubMed ID: 1524885
    [No Abstract]   [Full Text] [Related]  

  • 55. Exploring the Safety Profile of Ornidazole as Drug Candidate for Endometriosis Treatment.
    Barra F; Perrone U; Iasci A; Ferrero S; Bogliolo S
    Gynecol Obstet Invest; 2023; 88(3):185-186. PubMed ID: 37015203
    [No Abstract]   [Full Text] [Related]  

  • 56. An Investigation of the Clinical Effects of Lævo-Rotary and Dextro-Rotary Hyoscine.
    Moir JC
    Trans Edinb Obstet Soc; 1925; 45():35-39. PubMed ID: 29612304
    [No Abstract]   [Full Text] [Related]  

  • 57. Chiral knife edge: A simplified rattleback to illustrate spin inversion.
    Jagla EA; Rojo AG
    Phys Rev E; 2023 Dec; 108(6-1):064213. PubMed ID: 38243519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction to: Treatment with Laevo (L)-carnitine reverses the mitochondrial function of human embryos.
    Morimoto N; Hashimoto S; Yamanaka M; Satoh M; Nakaoka Y; Fukui A; Morimoto Y; Shibahara H
    J Assist Reprod Genet; 2021 Jun; 38(6):1601. PubMed ID: 33931821
    [No Abstract]   [Full Text] [Related]  

  • 59. Two Per Cent. Epinephrin Solutions as Substitutes for Laevo-Glaucosan.
    Green J
    Trans Am Ophthalmol Soc; 1930; 28():301-5. PubMed ID: 16692867
    [No Abstract]   [Full Text] [Related]  

  • 60. Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria.
    Marcus Y; Tal N; Ronen M; Carmieli R; Gurevitz M
    Biochem J; 2017 Dec; 474(24):4269. PubMed ID: 29242382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.